Clinical trial
Post-marketing Database Study in Patients With Graft-Versus Host Disease for JAKAVI Tablets
NCT07594587 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-marketing Database Study in Patients With Graft-Versus Host Disease for JAKAVI Tablets
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 11, 2026
- Completion date
- May 15, 2030
- Enrollment
- 395 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
graft-versus-host disease